Waters Corporation $WAT Shares Sold by Figure 8 Investment Strategies LLC

Key Points

• Figure 8 Investment Strategies LLC reduced its stake in Waters Corporation by 26.6%, selling 1,924 shares and holding 5,322 shares at the end of the latest quarter, which is worth approximately $1.86 million.
• Multiple hedge funds have adjusted their positions in Waters, with UMB Bank n.a. increasing its holdings by 2.8%, while Horizon Investments LLC raised its stake by 5.2% in the first quarter.
• Waters Corporation reported earnings of $2.95 per share, surpassing estimates, with a quarterly revenue increase of 8.8% year-over-year, and has set guidance for Q3 2025 of 3.150-3.250 EPS.

Figure 8 Investment Strategies LLC cut its position in shares of Waters Corporation (NYSE:WAT - Free Report) by 26.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,322 shares of the medical instruments supplier's stock after selling 1,924 shares during the period. Waters makes up 1.8% of Figure 8 Investment Strategies LLC's holdings, making the stock its 20th biggest holding. Figure 8 Investment Strategies LLC's holdings in Waters were worth $1,858,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. UMB Bank n.a. boosted its holdings in Waters by 2.8% during the 2nd quarter. UMB Bank n.a. now owns 1,055 shares of the medical instruments supplier's stock valued at $368,000 after acquiring an additional 29 shares during the period. Integrated Wealth Concepts LLC lifted its position in shares of Waters by 2.9% during the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier's stock worth $386,000 after purchasing an additional 30 shares in the last quarter. FourThought Financial Partners LLC boosted its stake in shares of Waters by 5.1% in the first quarter. FourThought Financial Partners LLC now owns 658 shares of the medical instruments supplier's stock valued at $243,000 after purchasing an additional 32 shares during the period. Brown Advisory Inc. grew its holdings in shares of Waters by 0.8% in the first quarter. Brown Advisory Inc. now owns 5,498 shares of the medical instruments supplier's stock valued at $2,026,000 after purchasing an additional 42 shares in the last quarter. Finally, Horizon Investments LLC increased its stake in Waters by 5.2% during the 1st quarter. Horizon Investments LLC now owns 852 shares of the medical instruments supplier's stock worth $314,000 after buying an additional 42 shares during the period. Hedge funds and other institutional investors own 94.01% of the company's stock.

Waters Stock Up 2.2%

Shares of NYSE WAT opened at $328.95 on Friday. The business has a 50-day moving average of $296.92 and a two-hundred day moving average of $325.60. The company has a market capitalization of $19.58 billion, a price-to-earnings ratio of 29.66, a price-to-earnings-growth ratio of 3.00 and a beta of 1.04. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $423.56. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22.

Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, topping the consensus estimate of $2.93 by $0.02. The business had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. Waters had a return on equity of 38.60% and a net margin of 21.71%.The business's quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter last year, the company earned $2.63 EPS. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. On average, analysts forecast that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have commented on WAT. Weiss Ratings reissued a "hold (c)" rating on shares of Waters in a research report on Saturday, September 27th. Deutsche Bank Aktiengesellschaft set a $315.00 target price on Waters and gave the company a "hold" rating in a report on Tuesday, August 5th. Wells Fargo & Company cut their price target on Waters from $330.00 to $315.00 and set an "equal weight" rating on the stock in a report on Tuesday, August 5th. Jefferies Financial Group set a $385.00 price target on Waters and gave the company a "buy" rating in a research report on Monday, August 4th. Finally, Scotiabank reissued a "sector outperform" rating and set a $465.00 price objective on shares of Waters in a research report on Friday, July 11th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, Waters presently has a consensus rating of "Hold" and a consensus price target of $380.43.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.